Terms: = Lung cancer AND ENO2, HEL-S-279, NSE AND Staging
49 results:
1. Relevance of tumor markers for prognosis and predicting therapy response in non-small cell lung cancer patients: A CEPAC-TDM biomarker substudy.
Geiger K; Joerger M; Roessler M; Hettwer K; Ritter C; Simon K; Uhlig S; Holdenrieder S
Tumour Biol; 2024; 46(s1):S191-S206. PubMed ID: 38363625
[TBL] [Abstract] [Full Text] [Related]
2. Construction of the prognostic model for small-cell lung cancer based on inflammatory markers: A real-world study of 612 cases with eastern cooperative oncology group performance score 0-1.
Liu C; Jin B; Liu Y; Juhua O; Bao B; Yang B; Liu X; Yu P; Luo Y; Wang S; Teng Z; Song N; Qu J; Zhao J; Chen Y; Qu X; Zhang L
Cancer Med; 2023 Apr; 12(8):9527-9540. PubMed ID: 37015898
[TBL] [Abstract] [Full Text] [Related]
3. Detection of Changes in CEA and ProGRP Levels in BALF of Patients with Peripheral lung cancer and the Relationship with CT Signs.
Huang J; Ren K
Contrast Media Mol Imaging; 2023; 2023():1421709. PubMed ID: 36851977
[TBL] [Abstract] [Full Text] [Related]
4. Diagnostic value of lncRNA HOTAIR as a biomarker for detecting and staging of non-small cell lung cancer.
Yao X; Wang T; Sun MY; Yuming Y; Guixin D; Liu J
Biomarkers; 2022 Sep; 27(6):526-533. PubMed ID: 35959801
[No Abstract] [Full Text] [Related]
5. [On detection of chromogranin A, synaptophysin, neuronspecific enolase and progastrin-releasing peptide in small cell lung cancer].
Lu QQ; Li J; Li YH; Liu H; Xie XB
Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Jul; 56(7):1017-1022. PubMed ID: 35899358
[TBL] [Abstract] [Full Text] [Related]
6. Diagnostic value of HSP90α and related markers in lung cancer.
Yuan Z; Wang L; Hong S; Shi C; Yuan B
J Clin Lab Anal; 2022 Jun; 36(6):e24462. PubMed ID: 35522136
[TBL] [Abstract] [Full Text] [Related]
7. Value of pretreatment serum lactate dehydrogenase as a prognostic and predictive factor for small-cell lung cancer patients treated with first-line platinum-containing chemotherapy.
He M; Chi X; Shi X; Sun Y; Yang X; Wang L; Wang B; Li H
Thorac Cancer; 2021 Dec; 12(23):3101-3109. PubMed ID: 34725930
[TBL] [Abstract] [Full Text] [Related]
8. Genetic Mutation Analysis in Small Cell lung cancer by a Novel NGS-Based Targeted Resequencing Gene Panel and Relation with Clinical Features.
Jin W; Lei Z; Xu S; Fachen Z; Yixiang Z; Shilei Z; Tao G; Zhe S; Fengzhou L; Su WH; Chundong G
Biomed Res Int; 2021; 2021():3609028. PubMed ID: 33880365
[TBL] [Abstract] [Full Text] [Related]
9. Clinical significance of serum neuron-specific enolase in gastric adenocarcinoma.
Luo H; Shen K; Sun H; Li R; Wang Z; Xie Z
Medicine (Baltimore); 2020 Apr; 99(16):e19829. PubMed ID: 32312004
[TBL] [Abstract] [Full Text] [Related]
10. [Establishment of cut-off value of serum pro-gastrin-releasing peptide for diagnosis of small cell lung cancer and evaluation on the clinical diagnosis efficiency].
Shen D; Han BB; Chen F; Wei BJ; Cui CJ; Wang GJ; Cui W
Zhonghua Yi Xue Za Zhi; 2017 Sep; 97(34):2657-2662. PubMed ID: 28910952
[No Abstract] [Full Text] [Related]
11. A wireless point-of-care testing system for the detection of neuron-specific enolase with microfluidic paper-based analytical devices.
Fan Y; Liu J; Wang Y; Luo J; Xu H; Xu S; Cai X
Biosens Bioelectron; 2017 Sep; 95():60-66. PubMed ID: 28412662
[TBL] [Abstract] [Full Text] [Related]
12. [Utility of nse, ProGRP and LDH in Diagnosis and Treatment
in Patients with Small Cell lung cancer].
Peng Y; Wang Y; Li J; Hao X; Hu X
Zhongguo Fei Ai Za Zhi; 2016 Sep; 19(9):590-4. PubMed ID: 27666548
[TBL] [Abstract] [Full Text] [Related]
13. The prognostic factors in the elderly patients with small cell lung cancer: a retrospective analysis from a single cancer institute.
Liu S; Guo H; Kong L; Li H; Zhang Y; Zhu H; Yu J
Int J Clin Exp Pathol; 2015; 8(9):11033-41. PubMed ID: 26617821
[TBL] [Abstract] [Full Text] [Related]
14. Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects.
Isgrò MA; Bottoni P; Scatena R
Adv Exp Med Biol; 2015; 867():125-43. PubMed ID: 26530364
[TBL] [Abstract] [Full Text] [Related]
15. The prognostic significance of the circulating neuroendocrine markers chromogranin A, pro-gastrin-releasing peptide, and neuron-specific enolase in patients with small-cell lung cancer.
Petrović M; Bukumirić Z; Zdravković V; Mitrović S; Atkinson HD; Jurišić V
Med Oncol; 2014 Feb; 31(2):823. PubMed ID: 24375395
[TBL] [Abstract] [Full Text] [Related]
16. Cytokeratin-19 fragments, nucleosomes and neuron-specific enolase as early measures of chemotherapy response in non-small cell lung cancer.
Alm El-Din MA; Farouk G; Nagy H; Abd Elzaher A; Abo El-Magd GH
Int J Biol Markers; 2012 Jul; 27(2):e139-46. PubMed ID: 22467097
[TBL] [Abstract] [Full Text] [Related]
17. [Clinical utility of serum tumor markers in lung cancer].
Zhao X; Wang M
Zhongguo Fei Ai Za Zhi; 2011 Mar; 14(3):286-91. PubMed ID: 21426676
[TBL] [Abstract] [Full Text] [Related]
18. [Role of biological tumor markers CEA, Cyfra-21, nse, TU M2-PK in diagnosis and treatment of lung cancer].
Lazarev SM; Massard Zh; Reshetov AV; Nikolaev GV; Volgin GN; Osipov EV; Lomteva EIu; Nokhrin AV; Kakysheva OE
Vestn Khir Im I I Grek; 2010; 169(1):39-43. PubMed ID: 20387605
[TBL] [Abstract] [Full Text] [Related]
19. Neuron-specific enolase and lung cancer.
Karnak D; Beder S; Kayacan O; Ibiş E; Oflaz G
Am J Clin Oncol; 2005 Dec; 28(6):586-90. PubMed ID: 16317269
[TBL] [Abstract] [Full Text] [Related]
20. Increased CYFRA 21-1 and CEA levels are negative predictors of outcome in p-stage I NSCLC.
Muley T; Dienemann H; Ebert W
Anticancer Res; 2003; 23(5b):4085-93. PubMed ID: 14666606
[TBL] [Abstract] [Full Text] [Related]
[Next]
